Stem Cell Technology Articles & Analysis
8 articles found
Cell culture is one of the major technologies in the life sciences. It is a general term used to remove cells, tissues or organs from animals or plants and place them in an artificial environment conducive to their survival and/or proliferation. ...
Application in Biomedical Research Gene Expression Studies: Reporter lentiviral particles allow efficient tracking of specific gene expressions. For example, cells expressing the GFP reporter gene will produce a clear fluorescent signal, thus highlighting the cells expressing the gene of interest. ...
Induced pluripotent stem cells (iPSCs) can be generated from a wide range of fully differentiated cells and, under optimal conditions, can potentially be driven to differentiate into virtually any fate. Induced stem-like cells not only provide an alternative to embryonic stem ...
The high-content analysis of human engineered tissues is instrumental in drug discovery at their screening and lead optimization stage. The IVS proprietary technology allows the growth of engineered tissues in 3D to mimic healthy and disease-naive human tissues, which enables the gap to be bridged between cell based assays and studies using isolated ...
Regeneus is excited to announce it is partnering with the Australian Department of Defence to develop its platform stem cell bioactive secretome technology Sygenus for combat casualty care. ...
In the past, experts may have balked at the cost and difficulty of using primary human tissue: its limited viability; its need for multiple donors and the inconsistency this can bring; and its poor proliferative capacity. However, with new stem cell technologies, it is now possible to use primary human stem cells ...
Chimeric antigen receptor T-cells (CAR-T) are one of the first clinically approved therapies to take full advantage of the most significant advancements in immunology and genetic engineering. The resulting therapeutics have been shown to produce remission rates exceeding 80% in patients with CD19+ B-cell lymphoma, making them nothing short of remarkable [1]. Unfortunately, CAR-T cells seem ...
SAN FRANCISCO, CA--(Marketwired - Sep 11, 2015) - Aelan Cell Technologies announced today the addition of Meenakshi Gaur, Ph.D. to their stem cell clinical program. ...